Pyzchiva 130 mg IV Vial (Biosimilar to Stelara 130 mg) Ustekinumab 130mg/26mL IV Vial

$1,895.00

Drug Info: ApoThera Drug Disease Clinical Support App

– Prescription Required
– Free Next Day Delivery to Anywhere in CA and NY
– Free Same Day Delivery within 50-Mile Radius of ApoThera
– Concierge Pharmacy; Do NOT Accept Insurance
– Annual Concierge Pharmacy Membership Fee: $300/year
– Accept Credit Cards, Apple Pay and Zelle
– Do NOT accept manufacturer coupons
 
Physicians may send E-Prescriptions (E-Scripts) to:
ApoThera
45 Post, 2nd Floor
Irvine, CA 92618
Phone: (949)387-7711
Fax:      (949)387-7712
Crohn Disease
Induction 
– ≤55 kg: 260 mg IV x 1 dose
– 55 kg to 85 kg: – 390 mg IV x 1 dose
– >85 kg: 520 mg IV x 1 dose
Maintenance Dose
– 90 mg SC every 8 weeks
– Begin maintenance dosing 8 weeks after the IV induction dose
Manufacturer: Sandoz
NDC: 61314-0654-94 Category:

1 Vial = 1 Unit

Description

Drug Info: ApoThera Drug Disease Clinical Support App

IV Administration
– Infuse over at least 1 hour; use of IV set with an in-line, low-protein binding filter (0.2 micrometer) required
– Do not infuse concomitantly in the same IV line with other agents
Reconstitution
– After calculating the appropriate dosage and volume of ustekinumab (using 130 mg per 26 mL vials), withdraw an equal volume of fluid from 250 mL bag of NS and discard
– Add to the NS bag; final volume of bag should be 250 mL
– Gently mix bag.
Storage
Intact Vials
– Refrigerate vials at 2°C to 8°C (36°F to 46°F)
– Do not freeze
– Store vials upright
– Keep the product in the original carton to protect from light until the time of use.
– Do not shake.
– Discard any unused portion
IV Infusion Solution
– Once diluted, solution for IV infusion may be stored up to 4 hours at room temperature (up to 25°C [77°F]).
 
Monitoring
– Tuberculosis screening (prior to initiating and periodically during therapy)
– CBC
– Ustekinumab-antibody formation
– Signs and symptoms of infection, reversible posterior leukoencephalopathy syndrome (RPLS), and squamous cell skin carcinoma
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Related Products